Oxymorphone Hydrochloride (CorePharma, LLC)
Welcome to the PulseAid listing for the Oxymorphone Hydrochloride drug offered from CorePharma, LLC. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | CorePharma, LLC |
NON-PROPRIETARY NAME: | Oxymorphone Hydrochloride |
SUBSTANCE NAME: | OXYMORPHONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-17 |
END MARKETING DATE: | 2017-12-31 |
Oxymorphone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Oxymorphone Hydrochloride from CorePharma, LLC |
LABELER NAME: | CorePharma, LLC |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2015-01-17 |
END MARKETING DATE: | 2017-12-31 |
PRODUCT ID: | 64720-259_02ce8356-dee5-4a7d-8d53-60343870697f |
PRODUCT NDC: | 64720-259 |
APPLICATION NUMBER: | ANDA201187 |
Other OXYMORPHONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: